Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657395 · ClinicalTrials.gov registry record · Phase 1
Root Coverage Using a Xenograph for Treatment of Gingival Recession
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT02657395: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT02657395 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02657395, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Can a fetal bovine derived membrane serve as an alternative to autogenous tissue for dental root coverage procedures.
Interventions
- DEVICE PriMatrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02657395
The ClinicalTrials.gov registry entry for NCT02657395 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PriMatrix is the first listed.
NCT02657395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02657395 about?
NCT02657395 is a clinical study titled "Root Coverage Using a Xenograph for Treatment of Gingival Recession". Can a fetal bovine derived membrane serve as an alternative to autogenous tissue for dental root coverage procedures.
What is the current status of trial NCT02657395?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2015-10. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02657395?
The interventions under investigation include: PriMatrix (DEVICE).
Who is sponsoring clinical trial NCT02657395?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.